August 14, 2019

Where Are We in the Search for Better Treatments? Dr. Scott Turner, Georgetown University


Current treatments for Alzheimer's disease have only minimal and temporary benefits. While the search for more effective Alzheimer’s treatments has seen many disappointments in recent years, the pipeline of drugs in development is far from empty.

ResearchersAgainstAlzheimer’s released its 2019 state-of-the pipeline report, and the findings give cause for optimism. A broader range of ideas is being considered to fight the disease, including three new pathways to attack Alzheimer’s that have emerged in the past year alone. In addition, drugs that target amyloid – historically one of the most popular targets of potential Alzheimer’s drugs – have increased 30% since 2017, showing continued interest in the amyloid pathway. And, researchers believe an effective Alzheimer’s treatment may lie in a “cocktail”—a combination of drugs that target various pathways to treat the disease. Finally, the first wave of Alzheimer's prevention trials is well underway - with results available in coming years.

Press 'Play' button under the image at left to hear the full session.

Alzheimer's Talks host Meryl Comer speaks with one of the nation’s leading Alzheimer’s disease researchers, Dr. R. Scott Turner, director of the Georgetown University Memory Disorders Program, about the current Alzheimer's drug pipeline and related questions of diagnosis and prevention methods.